Literature DB >> 26678634

Differences in health care use and outcomes by the timing of in-hospital worsening heart failure.

Lauren B Cooper1, Bradley G Hammill2, Puza P Sharma3, Adam D DeVore4, Robert J Mentz4, Gregg C Fonarow5, Peter S Pang6, Lesley H Curtis4, Adrian F Hernandez4.   

Abstract

BACKGROUND: Patients hospitalized with acute heart failure may experience worsening symptoms requiring escalation of therapy. In-hospital worsening heart failure is associated with worse in-hospital and postdischarge outcomes, but associations between the timing of worsening heart failure and outcomes are unknown.
METHODS: Using data from a large clinical registry linked to Medicare claims, we examined characteristics, outcomes, and costs of patients hospitalized for acute heart failure. We defined in-hospital worsening heart failure by the use of inotropes or intravenous vasodilators or initiation of mechanical circulatory support, hemodialysis, or ventilation. The study groups were early worsening heart failure (n = 1,990), late worsening heart failure (n = 4,223), complicated presentation (n = 15,361), and uncomplicated hospital course (n = 41,334).
RESULTS: Among 62,908 patients, those with late in-hospital worsening heart failure had higher in-hospital and postdischarge mortality than patients with early worsening heart failure or complicated presentation. Those with early or late worsening heart failure had more frequent all-cause and heart failure readmissions at 30 days and 1 year, with resultant higher costs, compared with patients with an uncomplicated hospital course.
CONCLUSION: Although late worsening heart failure was associated with the highest mortality, both early and late worsening heart failures were associated with more frequent readmissions and higher health care costs compared to uncomplicated hospital course. Prevention of worsening heart failure may be an important focus in the care of hospitalized patients with acute heart failure.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26678634      PMCID: PMC4684593          DOI: 10.1016/j.ahj.2015.09.001

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

Authors:  Barry M Massie; Christopher M O'Connor; Marco Metra; Piotr Ponikowski; John R Teerlink; Gad Cotter; Beth Davison Weatherley; John G F Cleland; Michael M Givertz; Adriaan Voors; Paul DeLucca; George A Mansoor; Christina M Salerno; Daniel M Bloomfield; Howard C Dittrich
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

2.  Design of the RELAXin in acute heart failure study.

Authors:  Piotr Ponikowski; Marco Metra; John R Teerlink; Elaine Unemori; G Michael Felker; Adriaan A Voors; Gerasimos Filippatos; Barry Greenberg; Sam L Teichman; Thomas Severin; Guenther Mueller-Velten; Gad Cotter; Beth A Davison
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

3.  Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries.

Authors:  Robb D Kociol; Bradley G Hammill; Gregg C Fonarow; Winslow Klaskala; Roger M Mills; Adrian F Hernandez; Lesley H Curtis
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

4.  Effect of nesiritide in patients with acute decompensated heart failure.

Authors:  C M O'Connor; R C Starling; A F Hernandez; P W Armstrong; K Dickstein; V Hasselblad; G M Heizer; M Komajda; B M Massie; J J V McMurray; M S Nieminen; C J Reist; J L Rouleau; K Swedberg; K F Adams; S D Anker; D Atar; A Battler; R Botero; N R Bohidar; J Butler; N Clausell; R Corbalán; M R Costanzo; U Dahlstrom; L I Deckelbaum; R Diaz; M E Dunlap; J A Ezekowitz; D Feldman; G M Felker; G C Fonarow; D Gennevois; S S Gottlieb; J A Hill; J E Hollander; J G Howlett; M P Hudson; R D Kociol; H Krum; A Laucevicius; W C Levy; G F Méndez; M Metra; S Mittal; B-H Oh; N L Pereira; P Ponikowski; W H W Tang; W H Wilson; S Tanomsup; J R Teerlink; F Triposkiadis; R W Troughton; A A Voors; D J Whellan; F Zannad; R M Califf
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

5.  Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Authors:  John R Teerlink; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Piotr Ponikowski; Elaine Unemori; Adriaan A Voors; Kirkwood F Adams; Maria I Dorobantu; Liliana R Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Peter S Pang; Karl Werdan; Sam L Teichman; Angelo Trapani; Christopher A Bush; Rajnish Saini; Christoph Schumacher; Thomas M Severin; Marco Metra
Journal:  Lancet       Date:  2012-11-07       Impact factor: 79.321

6.  Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.

Authors:  Gad Cotter; Marco Metra; Beth Davison Weatherley; Howard C Dittrich; Barry M Massie; Piotr Ponikowski; Daniel M Bloomfield; Christopher M O'Connor
Journal:  Cardiology       Date:  2009-10-20       Impact factor: 1.869

7.  Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?

Authors:  Beth Davison Weatherley; Olga Milo-Cotter; G Michael Felker; Nir Uriel; Edo Kaluski; Zvi Vered; Christopher M O'Connor; Kirkwood F Adams; Gad Cotter
Journal:  Fundam Clin Pharmacol       Date:  2009-07-28       Impact factor: 2.748

8.  Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

Authors:  Milton Packer; Wilson Colucci; Lloyd Fisher; Barry M Massie; John R Teerlink; James Young; Robert J Padley; Roopal Thakkar; Leticia Delgado-Herrera; Jeffrey Salon; Chris Garratt; Bidan Huang; Toni Sarapohja
Journal:  JACC Heart Fail       Date:  2013-04-01       Impact factor: 12.035

9.  Linking inpatient clinical registry data to Medicare claims data using indirect identifiers.

Authors:  Bradley G Hammill; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow; Kevin A Schulman; Lesley H Curtis
Journal:  Am Heart J       Date:  2009-06       Impact factor: 4.749

10.  In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization.

Authors:  Adam D DeVore; Bradley G Hammill; Puza P Sharma; Laura G Qualls; Robert J Mentz; Katherine Waltman Johnson; Gregg C Fonarow; Lesley H Curtis; Adrian F Hernandez
Journal:  J Am Heart Assoc       Date:  2014-07-11       Impact factor: 5.501

View more
  1 in total

1.  Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization.

Authors:  David Snipelisky; Marat Fudim; Antonio Perez; Matthew Nayor; Natasha M Lever; David S Raymer; Andrew N Rosenbaum; Omar AbouEzzeddine; Adrian F Hernandez; Lynne Warner Stevenson; Lauren G Gilstrap
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.